The COVID-19 pandemic continues to rage on worldwide. Data surrounding the treatment of patients with COVID-19 respiratory failure is moving at lightning pace, so for this week's episode we will discuss the latest (as of 8/13/20) information surrounding two modalities for COVID-19 treatment: convalescent plasma and tocilizumab.
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
